EMA Recommends Extension of Indications for Darolutamide
New indication concerns the treatment of patients with metastatic hormone-sensitive prostate cancer in combination with docetaxel and androgen deprivation therapy
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
New indication concerns the treatment of patients with metastatic hormone-sensitive prostate cancer in combination with docetaxel and androgen deprivation therapy
Findings from the GALAXY, an observational arm of the ongoing CIRCULATE-Japan study
Evidence for efficacy is based on the results from the SEQUOIA and ALPINE studies
Findings from the FOxTROT study
Evidence for efficacy is based on the results from the MOUNTAINEER study
Findings from the FOENIX-CCA2 study
Findings from a correlative analysis of the CALGB 40601 and PAMELA studies in patients with early HER2-positive breast cancer
Findings highlight a complex relationship between immune-related adverse events and clinical outcome
Evidence for efficacy is based on the results from the Study CS-003
An unexpected increase in the number of thromboembolic events observed in crizotinib arm of the ANHL12P1 study
Findings from the KEYNOTE-045 study in patients with platinum-resistant metastatic urothelial cancer and from the KEYNOTE-052 as first-line treatment for cisplatin-ineligible patients
The results of a phase II study of neoadjuvant pembrolizumab for patients with localised mismatch repair deficient/microsatellite instability-high solid tumours
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.